These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 25495384

  • 1. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study.
    Soran A, Ozmen T, McGuire KP, Diego EJ, McAuliffe PF, Bonaventura M, Ahrendt GM, DeGore L, Johnson R.
    Lymphat Res Biol; 2014 Dec; 12(4):289-94. PubMed ID: 25495384
    [Abstract] [Full Text] [Related]

  • 2. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.
    Helyer LK, Varnic M, Le LW, Leong W, McCready D.
    Breast J; 2010 Dec; 16(1):48-54. PubMed ID: 19889169
    [Abstract] [Full Text] [Related]

  • 3. Breast cancer-related lymphedema after axillary lymph node dissection: does early postoperative prediction model work?
    Soran A, Menekse E, Girgis M, DeGore L, Johnson R.
    Support Care Cancer; 2016 Mar; 24(3):1413-9. PubMed ID: 26349574
    [Abstract] [Full Text] [Related]

  • 4. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.
    Armer J, Fu MR, Wainstock JM, Zagar E, Jacobs LK.
    Lymphology; 2004 Jun; 37(2):73-91. PubMed ID: 15328760
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer.
    Rebegea L, Firescu D, Dumitru M, Anghel R.
    Chirurgia (Bucur); 2015 Jun; 110(1):33-7. PubMed ID: 25800313
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors.
    McLaughlin SA, Wright MJ, Morris KT, Sampson MR, Brockway JP, Hurley KE, Riedel ER, Van Zee KJ.
    J Clin Oncol; 2008 Nov 10; 26(32):5220-6. PubMed ID: 18838708
    [Abstract] [Full Text] [Related]

  • 11. Upper limb physical function and adverse effects after breast cancer surgery: a prospective 2.5-year follow-up study and preoperative measures.
    Sagen A, Kaaresen R, Sandvik L, Thune I, Risberg MA.
    Arch Phys Med Rehabil; 2014 May 10; 95(5):875-81. PubMed ID: 24389401
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Axillary reverse mapping: a prospective study in women with clinically node negative and node positive breast cancer.
    Connor C, McGinness M, Mammen J, Ranallo L, Lafaver S, Klemp J, Fan F, Mahnken J.
    Ann Surg Oncol; 2013 Oct 10; 20(10):3303-7. PubMed ID: 23975287
    [Abstract] [Full Text] [Related]

  • 14. Use of a prospective surveillance model to prevent breast cancer treatment-related lymphedema: a single-center experience.
    Yang EJ, Ahn S, Kim EK, Kang E, Park Y, Lim JY, Kim SW.
    Breast Cancer Res Treat; 2016 Nov 10; 160(2):269-276. PubMed ID: 27665585
    [Abstract] [Full Text] [Related]

  • 15. Sentinel node biopsy and quality of life measures in a Chinese population.
    Chen JJ, Huang XY, Liu ZB, Chen TW, Cheng JY, Yang WT, Xu WP, Shao ZM, Shen ZZ, Wu J.
    Eur J Surg Oncol; 2009 Sep 10; 35(9):921-7. PubMed ID: 19233602
    [Abstract] [Full Text] [Related]

  • 16. Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients.
    Specht MC, Miller CL, Skolny MN, Jammallo LS, O'Toole J, Horick N, Isakoff SJ, Smith BL, Taghian AG.
    Ann Surg Oncol; 2013 Sep 10; 20(9):2835-41. PubMed ID: 23689935
    [Abstract] [Full Text] [Related]

  • 17. Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection.
    Golshan M, Martin WJ, Dowlatshahi K.
    Am Surg; 2003 Mar 10; 69(3):209-11; discussion 212. PubMed ID: 12678476
    [Abstract] [Full Text] [Related]

  • 18. Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions.
    Kilgore LJ, Korentager SS, Hangge AN, Amin AL, Balanoff CR, Larson KE, Mitchell MP, Chen JG, Burgen E, Khan QJ, O'Dea AP, Nye L, Sharma P, Wagner JL.
    Ann Surg Oncol; 2018 Oct 10; 25(10):2948-2952. PubMed ID: 29987599
    [Abstract] [Full Text] [Related]

  • 19. Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema.
    Kaufman DI, Shah C, Vicini FA, Rizzi M.
    Breast Cancer Res Treat; 2017 Dec 10; 166(3):809-815. PubMed ID: 28831632
    [Abstract] [Full Text] [Related]

  • 20. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.
    Boneti C, Korourian S, Bland K, Cox K, Adkins LL, Henry-Tillman RS, Klimberg VS.
    J Am Coll Surg; 2008 May 10; 206(5):1038-42; discussion 1042-4. PubMed ID: 18471751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.